Despite not being HNSCC-specific, the results are consistent with previous research employing various cancer models and raise the prospect of a therapeutic window for Bmi-1 targeting [10,11,30,37,39]. This evidence concerns the gene BMI1 and head and neck squamous cell carcinoma.